Highdose hypofractionated Xray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities

By                  

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1514-1520

Spandidos Publications

Access to resources Recommend Favorite

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

By Church D.   Bahl A.   Jones A.   Price C.  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

By Marcom P.   Isaacs Claudine   Harris Lyndsay   Wong Zee   Kommarreddy Aruna   Novielli Nellie   Mann Gretchen   Tao Yu   Ellis Matthew  

Breast Cancer Research and Treatment, Vol. 102, Iss. 1, 2007-03 ,pp. : 43-49

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab Monotherapy

By Vogel Charles  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 67-68

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic insights into the future of trastuzumab

By Leyland-Jones B.   Arnold A.   Gelmon K.   Verma S.     Seidman A.   Dias R.   Howell J.   Rakhit A.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite